InfeXn Laboratories Pvt Ltd

Home
India
Thane
InfeXn Laboratories Pvt Ltd

We at Infexn work tirelessly towards our mission to expertise and expand the scope of laboratory dia

22/06/2026

In the era of rising antimicrobial resistance, accurate Drug Susceptibility Testing (DST) plays a crucial role in enabling targeted therapy.

At InfeXn Laboratories, our BD Phoenix™️ Automated ID/AST System supports clinicians with:
* Accurate identification of Gram-positive & Gram-negative pathogens
* Comprehensive antibiotic susceptibility profiles
* MIC-based reporting for informed therapeutic decisions

Helping clinicians move from empirical choices to evidence-based antimicrobial management.

Right pathogen. Right antibiotic. Better outcomes.

21/06/2026

International Yoga Day | June 21st 🧘‍♀️

Yoga is more than a physical practice — it is a discipline that supports harmony between the body, mind, and natural biological rhythms.

Through mindful movement, breathing practices, and meditation, yoga helps:
* Improve respiratory function and circulation
* Support stress regulation and mental balance
* Enhance sleep, metabolism, and overall well-being
* Maintain the body’s natural defence mechanisms

A balanced body with an active immune response is better equipped to maintain health and resilience.

At InfeXn Laboratories, we align with the spirit of International Yoga Day — June 21st, celebrating the importance of prevention, awareness, and a healthier way of living.

Stay balanced. Stay aware. Stay healthy. 🌿

15/06/2026

🧬 Advancing Microbial Identification with MALDI-TOF

Rapid and accurate species-level identification is essential for effective clinical microbiology. The Bruker MALDI Biotyper Sirius identifies microorganisms by matching their unique proteomic fingerprints against an extensive reference library, enabling reliable identification of routine bacteria, yeasts, non-tuberculous mycobacteria (NTM), Mycobacterium tuberculosis (TB), and filamentous fungi (molds).

This technology supports timely, evidence-based clinical decision-making by delivering precise microbial identification for routine diagnostic workflows.

08/06/2026

Beta-D-Glucan (BDG) is a reliable non-culture-based biomarker that can support the early detection of invasive fungal infections. By providing valuable diagnostic insights before culture results are available, BDG testing can help inform clinical decision-making.

In high-risk patients—such as transplant recipients, hematology patients, and the immunocompromised—waiting for culture confirmation may delay important treatment decisions.

⏱️ At InfeXn Laboratories, we offer the Beta-D-Glucan Assay with a 48-hour turnaround time to support faster clinical decision-making.

05/06/2026

🌍 World Environment Day reminds us that a healthier planet begins with healthier environments—including healthcare facilities.

At Infexn Laboratories, we support sustainable healthcare through environmental monitoring and infection control surveillance that helps:

✅ Detect environmental microbial contamination early
✅ Reduce Hospital-Acquired Infection (HAI) risks
✅ Support NABH, NABL, and WHO compliance
✅ Enable data-driven corrective actions
✅ Maintain safer and cleaner healthcare environments

By strengthening infection prevention practices, we contribute to improved patient outcomes, responsible antimicrobial use, and a more sustainable healthcare ecosystem.

🌱 Cleaner Hospitals. Safer Patients. Greener Future.

03/06/2026

When a patient presents with persistent joint pain, swelling, implant failure, or suspected osteoarticular infection, the biggest challenge is often identifying the causative pathogen quickly and accurately. Conventional methods may miss fastidious organisms or require prolonged turnaround times, delaying targeted treatment decisions.

🧪At InfeXn Laboratories, our Bone & Joint Multiplex RT-PCR Panel is designed to address this diagnostic gap by enabling rapid molecular detection of clinically relevant bacterial and fungal pathogens, along with key antimicrobial resistance markers, from a single sample.

📈The result: earlier pathogen-directed therapy, improved antimicrobial stewardship, and better support for clinical decision-making in complex bone and joint infections.

01/06/2026

🩺 Clinicians often face a critical dilemma: initiate antifungal therapy empirically or wait for diagnostic confirmation.

Reliable biomarkers such as galactomannan can help support timely and informed clinical decisions.

⚠️ In high-risk patients, waiting for culture confirmation may delay critical treatment decisions. Galactomannan testing provides clinicians with an evidence-based approach to support earlier identification of invasive Aspergillus infections, particularly when clinical suspicion is high.

A timely diagnosis can help guide targeted antifungal therapy and improve patient management 🎯.

⏱️ At InfeXn Laboratories, we offer the Aspergillus Galactomannan Assay with a 48-hour turnaround time to support faster clinical decision-making.

19/05/2026

Early detection can change the clinical outcome in rapidly progressing viral infections like Hantavirus.

In suspected Hantavirus infection, the diagnostic window is critical. During the acute viremic phase, RT-PCR offers higher clinical utility because it detects circulating viral RNA before a measurable antibody response develops.

Patients presenting early with fever, myalgia, thrombocytopenia, or respiratory involvement may still remain IgM seronegative initially, making molecular detection essential for timely diagnosis and clinical management.

RT-PCR therefore provides a significant advantage for early case identification, while IgM serology becomes more reliable later once the humoral immune response is established.

At InfeXn Laboratories, Hantavirus RT-PCR testing is available for early molecular detection in clinically suspected cases.

16/05/2026

India has reported 289,235 dengue cases and 485 deaths in recent years — the highest in the past five years. While most infections are mild, some patients may develop severe dengue with complications such as hemorrhage, shock, and organ failure, making early diagnosis essential. 🦟⚠️

🧪 Molecular diagnostics like Dengue RT-PCR and syndromic multiplex PCR panels support early detection, even before antibodies are detectable.

At InfeXn Lab, we are committed to enabling early dengue detection and better patient care. 🏥🔬

14/05/2026

Epstein-Barr Virus (EBV) infection can pose serious clinical challenges, especially in immunocompromised, transplant, and oncology patients.

Reactivation of the virus is associated with complications such as lymphoproliferative disorders and EBV-associated malignancies.

Accurate diagnosis and real-time viral load monitoring through molecular techniques like qPCR play a crucial role in detecting active infection, guiding timely clinical decisions, and improving patient management.

Early intervention and continuous monitoring remain key to better infection control and patient care outcomes.

Address

Pride 16, Road No 16Z Opposite Ashar IT Park, Wagle Industrial Estate
Thane
400604

Telephone

+912225836546

Website

http://infexn.in/

Alerts

Be the first to know and let us send you an email when InfeXn Laboratories Pvt Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to InfeXn Laboratories Pvt Ltd:

Shortcuts

Want your practice to be the top-listed Clinic in Thane?